Multiplex Analysis of the Activation of the Immune System after Transection of the Rat’s Sciatic Nerve by Masgutova G. et al.
BioNanoScience 2017 vol.7 N1, pages 170-176
Multiplex Analysis of the Activation of the Immune
System after Transection of the Rat’s Sciatic Nerve
Masgutova G., Martynova E., Masgutov R., Mukhametova L., Mullakhmetova A., Kadyrova G.,
Khaiboullina S., Rizvanov A.
Kazan Federal University, 420008, Kremlevskaya 18, Kazan, Russia
Abstract
© 2016, Springer Science+Business Media New York.In this study, using the model of sciatic
nerve transection in rats, the cytokine profile of peripheral blood serum and rat sciatic nerve
fragments was measured 3, 7 and 14 days after the injury. Histological analysis of sciatic nerve
longitudinal  sections was carried out  at  the same periods of  time.  The cytokine profile  of
peripheral blood serum of an intact rat as well as the cytokine profile of an intact homogenized
sciatic nerve of a rat was examined. Comparative study of changes in quantitative measures
before and after the injury was carried out. It was shown that in peripheral blood serum after the
sciatic nerve transection, there was a change in quantitative measures of IL1a, Leptin, IL6,
MCP1, and MIP2. In the samples of the rat sciatic nerve, the changes were found in the levels of
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